Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-4379-3
Published September 2, 2026 · Recall initiated: August 13, 2026
Summary
FDA records drug Class II recall D-0804-2026, published September 2, 2026 and initiated August 13, 2026. Recalling firm: Apotex Corp.; Status: Ongoing; Reported quantity: 6,972 bottles; Lot: Lot # TY9494, Exp Date: 05/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
What to do
Voluntary: Firm initiated · Letter
Get an email if PAXIL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PAXIL
- Manufacturer
- Apotex Corp.
- Distributor
- US Nationwide.
- UPC
- 0360505366835
- Lot
- Lot # TY9494, Exp Date: 05/31/2027.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAActhar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARDSeptember 2, 2026
- FDATyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by FreseniusSeptember 2, 2026
- FDAZicam, Cold Remedy, Medicated Nasal Swabs, With Cooling Menthol & Eucalyptus, 20 Single-Use Swabs per carton,September 2, 2026
- FDARamipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDCSeptember 2, 2026
- FDAPAXIL CR (Paroxetine HCL) Controlled-Release Tablets 37.5 mg, 30-count bottle, Rx only, Manufactured bySeptember 10, 2014
- FDAPAXIL CR (Paroxetine HCL) Controlled-Release Tablets 25 mg, 30-count bottle, Rx only, Manufactured bySeptember 10, 2014
Questions about this recall
Was Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-4379-3 recalled?
Yes. FDA published recall D-0804-2026 on September 2, 2026. Reported hazard: Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PAXIL. UPC: 0360505366835.